Skip to main content

Peer Review reports

From: Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study

Original Submission
11 Jan 2017 Submitted Original manuscript
9 May 2017 Author responded Author comments - Evan Cunningham
3 Feb 2017 Reviewed Reviewer Report - Roberto Rossotti
4 Feb 2017 Reviewed Reviewer Report - Mario Masarone
26 Jan 2017 Reviewed Reviewer Report - Joop E Arends
7 Feb 2017 Reviewed Reviewer Report - Fabienne Marcellin
Resubmission - Version 2
9 May 2017 Submitted Manuscript version 2
31 May 2017 Author responded Author comments - Evan Cunningham
Resubmission - Version 3
31 May 2017 Submitted Manuscript version 3
Publishing
1 Jun 2017 Editorially accepted
13 Jun 2017 Article published 10.1186/s12879-017-2517-3

You can find further information about peer review here.

Back to article page
\